Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aktis Oncology, Inc. | 7,570,168 | reported | 12 Jan 2026 | tx 7+9,918,355−33,500,000 |
| Werewolf Therapeutics, Inc. | 6,147,610 | reported | 03 Nov 2025 | tx 3−295,043 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 1,577,119 | — | |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 5,914,197 | — | |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 1,314,262 | — | |
| 12 Jan 2026 | PURCHASE | Aktis Oncology, Inc. | 1,112,777 | 18.00 USD | |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 22,500,000 | 0.00 USD | deriv |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 6,000,000 | 0.00 USD | deriv |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 5,000,000 | 0.00 USD | deriv |
| 30 Oct 2025 | SALE | Werewolf Therapeutics, Inc. | 86,936 | 1.43 USD | |
| 31 Oct 2025 | SALE | Werewolf Therapeutics, Inc. | 114,044 | 1.28 USD | |
| 03 Nov 2025 | SALE | Werewolf Therapeutics, Inc. | 94,063 | 1.29 USD |